The Company has enclosed herewith certificate received from RTA under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31.03.2025
KREBSBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Krebs Biochemicals and Industries Limited has submitted a certificate received from its Registrar and Transfer Agent (RTA) to the stock exchanges. This certificate has been filed under the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31 March 2025. Such certificates are typically issued by the RTA after reconciling the company's share capital records with the records held by depositories like NSDL and CDSL. This is a standard regulatory compliance requirement that all listed companies must fulfil on a quarterly basis. The filing confirms that the company's share capital data is in agreement between physical and dematerialised records.
This is a routine compliance filing with no material impact on shareholders, business operations, or the stock price. Investors should not read any signal into this disclosure beyond confirmation of regular regulatory adherence.